News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
871,263 Results
Type
Article (88063)
Company Profile (825)
Press Release (782355)
Multimedia
Podcasts (200)
Webinars (29)
Section
Business (233308)
Career Advice (4149)
Deals (39887)
Drug Delivery (151)
Drug Development (91448)
Employer Resources (205)
FDA (18406)
Job Trends (17434)
News (398010)
Policy (39977)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3015)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (153)
Alliances (56982)
ALS (183)
Alzheimer's disease (1807)
Antibody-drug conjugate (ADC) (355)
Approvals (18591)
Artificial intelligence (646)
Autoimmune disease (175)
Automation (40)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (205)
Biotechnology (490)
Bladder cancer (165)
Brain cancer (66)
Breast cancer (676)
Cancer (5131)
Cardiovascular disease (455)
Career advice (3573)
Career pathing (42)
CAR-T (312)
CDC (59)
Celiac Disease (2)
Cell therapy (852)
Cervical cancer (38)
Clinical research (77158)
Collaboration (1872)
Company closure (5)
Compensation (1193)
Complete response letters (75)
COVID-19 (2996)
CRISPR (99)
C-suite (906)
Cystic fibrosis (155)
Data (6394)
Decentralized trials (2)
Denatured (74)
Depression (153)
Diabetes (541)
Diagnostics (7258)
Digital health (53)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (314)
Drug pricing (227)
Drug shortages (36)
Duchenne muscular dystrophy (246)
Earnings (100325)
Editorial (66)
Employer branding (25)
Employer resources (174)
Events (135289)
Executive appointments (1047)
FDA (21656)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1588)
Gene editing (219)
Generative AI (69)
Gene therapy (689)
GLP-1 (1146)
Government (5457)
Grass and pollen (8)
Guidances (387)
Healthcare (20958)
HIV (66)
Huntington's disease (50)
IgA nephropathy (86)
Immunology and inflammation (301)
Immuno-oncology (65)
Indications (110)
Infectious disease (3292)
Inflammatory bowel disease (207)
Inflation Reduction Act (17)
Influenza (126)
Intellectual property (256)
Interviews (816)
IPO (17966)
IRA (61)
Job creations (5201)
Job search strategy (2867)
JPM (71)
Kidney cancer (17)
Labor market (96)
Layoffs (661)
Leadership (41)
Legal (10163)
Liver cancer (99)
Longevity (16)
Lung cancer (691)
Lymphoma (385)
Machine learning (45)
Management (66)
Manufacturing (880)
MASH (177)
Medical device (15058)
Medtech (15115)
Mergers & acquisitions (23010)
Metabolic disorders (1433)
Multiple sclerosis (170)
NASH (23)
Neurodegenerative disease (365)
Neuropsychiatric disorders (105)
Neuroscience (3161)
Neurotech (1)
NextGen: Class of 2026 (7709)
Non-profit (5116)
Now hiring (68)
Obesity (698)
Opinion (337)
Ovarian cancer (171)
Pain (218)
Pancreatic cancer (238)
Parkinson's disease (303)
Partnered (39)
Patents (519)
Patient recruitment (507)
Peanut (61)
People (67001)
Pharmaceutical (145)
Pharmacy benefit managers (33)
Phase 1 (23843)
Phase 2 (33485)
Phase 3 (25215)
Pipeline (5398)
Policy (342)
Postmarket research (3554)
Preclinical (10701)
Press Release (72)
Prostate cancer (253)
Psychedelics (58)
Radiopharmaceuticals (305)
Rare diseases (943)
Real estate (7442)
Recruiting (81)
Regulatory (29141)
Reports (68)
Research institute (2732)
Resumes & cover letters (652)
Rett syndrome (28)
RNA editing (21)
RSV (85)
Schizophrenia (160)
Series A (263)
Series B (204)
Service/supplier (30)
Sickle cell disease (104)
Special edition (27)
Spinal muscular atrophy (178)
Sponsored (48)
Startups (4336)
State (2)
Stomach cancer (20)
Supply chain (114)
Tariffs (101)
The Weekly (124)
Vaccines (1164)
Venture capital (100)
Weight loss (481)
Women's health (94)
Worklife (22)
Date
Today (143)
Last 7 days (646)
Last 30 days (2296)
Last 365 days (32876)
2026 (3574)
2025 (33230)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (92)
Alaska (7)
Arizona (347)
Arkansas (14)
Asia (51620)
Australia (9065)
California (11748)
Canada (3372)
China (1197)
Colorado (501)
Connecticut (508)
Delaware (354)
Europe (118625)
Florida (1729)
Georgia (376)
Hawaii (4)
Idaho (68)
Illinois (976)
India (73)
Indiana (552)
Iowa (24)
Japan (446)
Kansas (134)
Kentucky (43)
Louisiana (30)
Maine (83)
Maryland (1470)
Massachusetts (8642)
Michigan (367)
Minnesota (671)
Mississippi (6)
Missouri (142)
Montana (36)
Nebraska (29)
Nevada (127)
New Hampshire (86)
New Jersey (3156)
New Mexico (33)
New York (3101)
North Carolina (1636)
North Dakota (10)
Northern California (5644)
Ohio (359)
Oklahoma (23)
Oregon (55)
Pennsylvania (2344)
Puerto Rico (25)
Rhode Island (50)
South America (1665)
South Carolina (67)
South Dakota (1)
Southern California (4537)
Tennessee (180)
Texas (1854)
United States (42344)
Utah (352)
Vermont (1)
Virginia (295)
Washington D.C. (88)
Washington State (988)
West Virginia (4)
Wisconsin (132)
Wyoming (2)
There are 871,263 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Microbix Reports Results for Q1 2026
February 12, 2026
·
7 min read
Insights
Digital Pathology, AI and the Future of ADCs and HER2 Cancer Treatment
In this episode of Denatured, Jennifer C. Smith-Parker speaks with Dr. Rob Monroe and Jennifer Fakish at Danaher Corporation. They discuss how antibody drug conjugates (ADCs) are transforming cancer care. With AI-powered pathology, doctors can now measure HER2 more precisely to match patients with the best treatments.
February 12, 2026
·
1 min read
·
Jennifer Smith-Parker
Press Releases
Agios Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 12, 2026
·
10 min read
Press Releases
West Reports Fourth-Quarter and Full-Year 2025 Results
February 12, 2026
·
21 min read
Legal
AbbVie Sues HHS, CMS for Including Botox in Drug Price Negotiation Program
AbbVie contends that Botox should have been excluded from the IRA drug price negotiation program because it is a plasma-derived product.
February 12, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
February 12, 2026
·
3 min read
Press Releases
Zymeworks To Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 2, 2026
February 12, 2026
·
2 min read
GLP-1
Oral Wegovy Brings in Thousands of New GLP-1 Patients
The oral version of Wegovy has made GLP-1 medicines more accessible and acceptable to many patients who had steered clear of injectable versions, healthcare analytics firm Truveta suggests.
February 12, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Zeon Corporation Makes Strategic Investment in Chemify to Accelerate Digital Chemistry Innovation and Drive Development of New Materials Through State-of-the-Art Automated Molecular Design and Synthesis
February 12, 2026
·
2 min read
Press Releases
Mitsubishi Electric and Indian Institute of Technology Hyderabad Sign MOU to Strengthen Industry-Academia Collaboration
February 12, 2026
·
1 min read
1 of 87,127
Next
